Home Movie News Vivek Agnihotri, who challenged the mighty Salaar, could not secure a 1Cr...

Vivek Agnihotri, who challenged the mighty Salaar, could not secure a 1Cr opening for his film The Vaccine War

Director Vivek Ranjan Agnihotri is not only known for his films, but he is also popular to getting involved in controversies. He often talks bad or against the top stars in Bollywood, and he also targeted Prabhas indirectly in the preview interviews. Previously, Vivek Agnihotri had stated that he is not feared by the competition but for his latest film he could not even secure a meager opening of 1Cr for The Vaccine War, his latest film.

Before the release of the film, when a question was asked about competition with Salaar, He said he was not worrying about the competition, and he also added that the Kashmir Files won over Prabhas’s Radhe Shyam film before and for Salaar also it will happen the same. It is very well known that Salaar was supposed to be released on September 28th.

Now, the film, Salaar got postponed, and The Vaccine War has released yesterday and the movie got positive reviews but still, it did not even collect 1Cr net in India on the opening day.

Pallavi Joshi is the producer of The Vaccine War, who is also the wife of Vivek Ranjan Agnihotri. From selecting a stellar cast to be involved in the intriguing plot, the unit made all efforts to make the film an engrossing affair. The Vaccine War has been given the ‘U’ certification by CBFC.

The Vaccine War stars Nana Patekar, Pallavi Joshi, Raima Sen, Sapthami Gowda and Anupam Kher in pivotal roles. The flick also features Girija Oak, Nivedita Bhattacharya and Mohan Kapur.

Follow on Google News Follow on Whatsapp

We are hiring passionate and enthusiastic content writers who can create original stories. If you are interested in full time, part time or freelancing, email us at jobs@tracktollywood.com. You need to work a 5 hour shift and be available to write articles. Kindly include your sample articles. Applications without sample articles will not be encouraged.



Exit mobile version